Comparing the Incidence of Falls/Fractures in Parkinson's Disease Patients in the US Population von Kalilani, Linda, Asgharnejad, Mahnaz, Palokangas, Tuire, Durgin, Tracy

Volltext

The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study von Kalilani, Linda, Friesen, David, Boudiaf, Nada, Asgharnejad, Mahnaz

Volltext

A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain von Rascol, Olivier, Zesiewicz, Theresa, Chaudhuri, K. Ray, Asgharnejad, Mahnaz, Surmann, Erwin, Dohin, Elisabeth, Nilius, Sigrid, Bauer, Lars

Volltext

Population pharmacokinetics, enzyme occupancy, and pharmacodynamic modeling of soticlestat in patients with developmental and epileptic encephalopathies von Yin, Wei, Facius, Axel, Asgharnejad, Mahnaz, Lahu, Gëzim, Vakilynejad, Majid

Volltext

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome von Benitez, Arturo, Edens, Heather, Fishman, Jesse, Moran, Kimberly, Asgharnejad, Mahnaz

Volltext

Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers von Dijkstra, Francis, O’Donnell, Patricio, Klaassen, Erica, Buhl, Derek, Asgharnejad, Mahnaz, Rosen, Laura, Zuiker, Rob, van Gerven, Joop, Jacobs, Gabriël

Volltext

Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation von O’Donnell, Patricio, Dijkstra, Francis M., Damar, Ugur, Quanhong, Lei, de Goede, Annika A., Xu, Lin, Pascual-Leone, Andres, Buhl, Derek L., Zuiker, Rob, Ruijs, Titia Q., Heuberger, Jules A. A. C., MacMullin, Paul, Lubell, Martin, Asgharnejad, Mahnaz, Murthy, Venkatesha, Rotenberg, Alexander, Jacobs, Gabriel E., Rosen, Laura

Volltext

Population pharmacokinetics, enzyme occupancy, and 24S‐hydroxycholesterol modeling of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, in healthy adults von Yin, Wei, Facius, Axel, Wagner, Thomas, Tsai, Max, Asgharnejad, Mahnaz, Lahu, Gëzim, Vakilynejad, Majid

Volltext

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease von Hauser, Robert A, Slawek, Jaroslaw, Barone, Paolo, Dohin, Elisabeth, Surmann, Erwin, Asgharnejad, Mahnaz, Bauer, Lars

Volltext

Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function von Yin, Wei, Mitra, Pranab, Copalu, Veronique, Marbury, Thomas C., Rondon, Juan Carlos, Lawitz, Eric J., Lloyd, Valerie, Baratta, Mike, Asgharnejad, Mahnaz, Hui, Tom, Khan, Yasir

Volltext

Long-Term Treatment Effects of Soticlestat in Patients with Dravet Syndrome or Lennox–Gastaut Syndrome: Interim Data from the ENDYMION 1 Trial (S44.004) von YAO, YUAN, Dlugos, Dennis, Asgharnejad, Mahnaz, Mitra, Pranab, Murthy, Venkatesha

Volltext

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or... von Hahn, Cecil D., Jiang, Yuwu, Villanueva, Vicente, Zolnowska, Marta, Arkilo, Dimitrios, Hsiao, Samuel, Asgharnejad, Mahnaz, Dlugos, Dennis

Volltext

Proposed Mechanism of Action of Soticlestat as an Antiseizure Medication (P9-1.013) von Murthy, Naga Venkatesha, Asgharnejad, Mahnaz, Benitez, Arturo, Nakashima, Kosuke, Kondo, Shinichi

Volltext

Efficacy of Soticlestat Treatment by Seizure Type in Patients with Dravet Syndrome or Lennox–Gastaut Syndrome in a Phase 2, Randomized, Placebo-controlled Study (ELEKTRA) (P11-1.00... von Murthy, Venkatesha, Dlugos, Dennis, Khan, Yasir, Hsiao, Samuel, Benitez, Arturo, Asgharnejad, Mahnaz

Volltext

Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms von Targum, Steven D., Ge, Tingting, Asgharnejad, Mahnaz, Reksoprodjo, Petra, Singh, Jaskaran B., Murthy, Venkatesha

Volltext

Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label... von Demarest, Scott, Jeste, Shafali, Agarwal, Nitin, Arkilo, Dimitrios, Asgharnejad, Mahnaz, Hsiao, Samuel, Thibert, Ronald

Volltext

Concentration-QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study von Yin, Wei, Dote, Nobuhito, Fukase, Hiroyuki, Imazaki, Manami, Shimizu, Kohei, Takeda, Shinichi, Darpo, Borje, Xue, Hongqi, Asgharnejad, Mahnaz

Volltext

A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies von Halford, Jonathan J., Sperling, Michael R., Arkilo, Dimitrios, Asgharnejad, Mahnaz, Zinger, Celia, Xu, Rengyi, During, Matthew, French, Jacqueline A.

Volltext

INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia von Murthy, Venkatesha, Hanson, Elizabeth, DeMartinis, Nicholas, Asgharnejad, Mahnaz, Dong, Cheng, Evans, Rebecca, Ge, Tingting, Dunayevich, Eduardo, Singh, Jaskaran B., Ratti, Emiliangelo, Galderisi, Silvana

Volltext

A Phase 1b/2a Study to Examine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-935 as an Adjunctive Therapy in Subjects with Developmental and/or Epileptic... von Asgharnejad, Mahnaz, Paker, Asif, Xu, Rengyi, Lee, Deborah

Volltext